{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=D5W&page=2", "query": { "intervention": "D5W", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=D5W&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-15T20:42:46.502Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03829683", "title": "Vitamin C Infusion for TReatment in Sepsis and Alcoholic Hepatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alcoholic Hepatitis", "Sepsis" ], "interventions": [ { "name": "Vitamin C", "type": "DRUG" }, { "name": "Dextrose 5% in water", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Virginia Commonwealth University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2019-04-16", "completion_date": "2022-06-23", "has_results": true, "last_update_posted_date": "2023-08-28", "last_synced_at": "2026-09-15T20:42:46.502Z", "location_count": 1, "location_summary": "Richmond, Virginia", "locations": [ { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03829683" }, { "nct_id": "NCT00878254", "title": "Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Mantle-Cell Lymphoma" ], "interventions": [ { "name": "G-CSF", "type": "BIOLOGICAL" }, { "name": "Rituximab", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Ifosfamide", "type": "DRUG" }, { "name": "Leucovorin", "type": "DRUG" }, { "name": "Mesna", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2009-03-25", "completion_date": "2025-05-30", "has_results": true, "last_update_posted_date": "2025-07-23", "last_synced_at": "2026-09-15T20:42:46.502Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00878254" }, { "nct_id": "NCT01070810", "title": "Thiamine as a Metabolic Resuscitator in Septic Shock", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Septic Shock" ], "interventions": [ { "name": "D5W", "type": "DRUG" }, { "name": "Thiamine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Beth Israel Deaconess Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 88, "start_date": "2010-02", "completion_date": "2014-11", "has_results": true, "last_update_posted_date": "2017-05-15", "last_synced_at": "2026-09-15T20:42:46.502Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01070810" }, { "nct_id": "NCT00048568", "title": "A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Abatacept", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1250, "start_date": "2002-12", "completion_date": "2009-10", "has_results": true, "last_update_posted_date": "2011-12-05", "last_synced_at": "2026-09-15T20:42:46.502Z", "location_count": 48, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 45 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00048568" }, { "nct_id": "NCT07382596", "title": "Cervical Plexus Hydrodissection With D5W Versus NS for Treatment-Resistant PTSD", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "PTSD" ], "interventions": [ { "name": "Dextrose 5% in water bilateral injection", "type": "DRUG" }, { "name": "Normal saline bilateral injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dr. Dean Reeves Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "19 Years to 90 Years" }, "enrollment_count": 50, "start_date": "2026-05-16", "completion_date": "2030-04-01", "has_results": false, "last_update_posted_date": "2026-05-19", "last_synced_at": "2026-09-15T20:42:46.502Z", "location_count": 4, "location_summary": "Lexington, Kentucky • Portland, Oregon • Madison, Wisconsin", "locations": [ { "city": "Lexington", "state": "Kentucky" }, { "city": "Portland", "state": "Oregon" }, { "city": "Portland", "state": "Oregon" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT07382596" }, { "nct_id": "NCT03485053", "title": "A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Iron Deficiency Anemia" ], "interventions": [ { "name": "IOP Injection / MPB-1514", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "MegaPro Biomedical Co. Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 49, "start_date": "2018-11-29", "completion_date": "2021-08-31", "has_results": false, "last_update_posted_date": "2021-10-28", "last_synced_at": "2026-09-15T20:42:46.502Z", "location_count": 8, "location_summary": "Azusa, California • Northridge, California • Whittier, California + 5 more", "locations": [ { "city": "Azusa", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "Whittier", "state": "California" }, { "city": "Lauderdale Lakes", "state": "Florida" }, { "city": "Manhasset", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03485053" }, { "nct_id": "NCT01167569", "title": "Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Reperfusion Injury" ], "interventions": [ { "name": "Ascorbic Acid", "type": "DRUG" }, { "name": "5 % Dextrose Water or Normal Saline", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Rutgers, The State University of New Jersey", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 57, "start_date": "2007-10", "completion_date": "2013-04", "has_results": true, "last_update_posted_date": "2020-10-19", "last_synced_at": "2026-09-15T20:42:46.502Z", "location_count": 1, "location_summary": "New Brunswick, New Jersey", "locations": [ { "city": "New Brunswick", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01167569" }, { "nct_id": "NCT00186888", "title": "Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Retinoblastoma", "Retinal Neoplasm" ], "interventions": [ { "name": "Enucleation", "type": "PROCEDURE" }, { "name": "Vincristine, Carboplatin", "type": "DRUG" }, { "name": "Focal Therapies", "type": "PROCEDURE" }, { "name": "External Beam Radiation", "type": "RADIATION" }, { "name": "Vincristine and Topotecan", "type": "DRUG" }, { "name": "Vincristine + Carboplatin + Etoposide", "type": "DRUG" }, { "name": "vincristine, cyclophosphamide, and doxorubicin", "type": "DRUG" }, { "name": "Vincristine, Carboplatin and Etoposide", "type": "DRUG" }, { "name": "Periocular carboplatin", "type": "PROCEDURE" }, { "name": "G-CSF", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "DRUG", "RADIATION", "OTHER" ], "sponsor": "St. Jude Children's Research Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 107, "start_date": "2005-04-07", "completion_date": "2024-11-12", "has_results": true, "last_update_posted_date": "2025-09-04", "last_synced_at": "2026-09-15T20:42:46.502Z", "location_count": 1, "location_summary": "Memphis, Tennessee", "locations": [ { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00186888" }, { "nct_id": "NCT00020722", "title": "Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "therapeutic autologous lymphocytes", "type": "BIOLOGICAL" }, { "name": "Ifosfamide, carboplatin, and etoposide (ICE) regimen", "type": "DRUG" }, { "name": "Cyclophosphamide, Thiotepa, Carboplatin (CTC) or STAMP V (CTC)", "type": "DRUG" }, { "name": "Leukapheresis", "type": "PROCEDURE" }, { "name": "peripheral blood stem cell transplantation (PBSCT)", "type": "PROCEDURE" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "PROCEDURE" ], "sponsor": "Barbara Ann Karmanos Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "FEMALE", "summary": "18 Years to 120 Years · Female only" }, "enrollment_count": 7, "start_date": "2007-08", "completion_date": "2013-03", "has_results": true, "last_update_posted_date": "2016-02-17", "last_synced_at": "2026-09-15T20:42:46.502Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00020722" }, { "nct_id": "NCT06690281", "title": "A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gastrointestinal Carcinoma", "Pancreatic Cancer", "Hepatocellular Cancer", "Cholangiocarcinoma", "Duodenal Cancer", "Colorectal Cancer", "Small Bowel Cancer", "Metastatic Cancers" ], "interventions": [ { "name": "KRAS TCR-Transduced PBL", "type": "BIOLOGICAL" }, { "name": "Aldesleukin", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "72 Years", "sex": "ALL", "summary": "18 Years to 72 Years" }, "enrollment_count": 0, "start_date": "2025-09-09", "completion_date": "2025-09-09", "has_results": false, "last_update_posted_date": "2025-09-11", "last_synced_at": "2026-09-15T20:42:46.502Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06690281" } ] }